FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164716263> ?p ?o ?g. }

• W3164716263 endingPage "868" @default.
• W3164716263 startingPage "850" @default.
• W3164716263 abstract "Main Recommendations 1 ESGE recommends that the initial assessment of patients presenting with acute lower gastrointestinal bleeding should include: a history of co-morbidities and medications that promote bleeding; hemodynamic parameters; physical examination (including digital rectal examination); and laboratory markers. A risk score can be used to aid, but should not replace, clinician judgment. Strong recommendation, low quality evidence. 2 ESGE recommends that, in patients presenting with a self-limited bleed and no adverse clinical features, an Oakland score of ≤ 8 points can be used to guide the clinician decision to discharge the patient for outpatient investigation. Strong recommendation, moderate quality evidence. 3 ESGE recommends, in hemodynamically stable patients with acute lower gastrointestinal bleeding and no history of cardiovascular disease, a restrictive red blood cell transfusion strategy, with a hemoglobin threshold of ≤ 7 g/dL prompting red blood cell transfusion. A post-transfusion target hemoglobin concentration of 7–9 g/dL is desirable.Strong recommendation, low quality evidence. 4 ESGE recommends, in hemodynamically stable patients with acute lower gastrointestinal bleeding and a history of acute or chronic cardiovascular disease, a more liberal red blood cell transfusion strategy, with a hemoglobin threshold of ≤ 8 g/dL prompting red blood cell transfusion. A post-transfusion target hemoglobin concentration of ≥ 10 g/dL is desirable. Strong recommendation, low quality evidence. 5 ESGE recommends that, in patients with major acute lower gastrointestinal bleeding, colonoscopy should be performed sometime during their hospital stay because there is no high quality evidence that early colonoscopy influences patient outcomes. Strong recommendation, low quality of evidence. 6 ESGE recommends that patients with hemodynamic instability and suspected ongoing bleeding undergo computed tomography angiography before endoscopic or radiologic treatment to locate the site of bleeding. Strong recommendation, low quality evidence. 7 ESGE recommends withholding vitamin K antagonists in patients with major lower gastrointestinal bleeding and correcting their coagulopathy according to the severity of bleeding and their thrombotic risk. In patients with hemodynamic instability, we recommend administering intravenous vitamin K and four-factor prothrombin complex concentrate (PCC), or fresh frozen plasma if PCC is not available. Strong recommendation, low quality evidence. 8 ESGE recommends temporarily withholding direct oral anticoagulants at presentation in patients with major lower gastrointestinal bleeding. Strong recommendation, low quality evidence. 9 ESGE does not recommend withholding aspirin in patients taking low dose aspirin for secondary cardiovascular prevention. If withheld, low dose aspirin should be resumed, preferably within 5 days or even earlier if hemostasis is achieved or there is no further evidence of bleeding. Strong recommendation, moderate quality evidence. 10 ESGE does not recommend routinely discontinuing dual antiplatelet therapy (low dose aspirin and a P2Y12 receptor antagonist) before cardiology consultation. Continuation of the aspirin is recommended, whereas the P2Y12 receptor antagonist can be continued or temporarily interrupted according to the severity of bleeding and the ischemic risk. If interrupted, the P2Y12 receptor antagonist should be restarted within 5 days, if still indicated. Strong recommendation, low quality evidence." @default.
• W3164716263 created "2021-06-07" @default.
• W3164716263 creator A5003132774 @default.
• W3164716263 creator A5003597455 @default.
• W3164716263 creator A5009683322 @default.
• W3164716263 creator A5010265665 @default.
• W3164716263 creator A5011274609 @default.
• W3164716263 creator A5017642140 @default.
• W3164716263 creator A5025249542 @default.
• W3164716263 creator A5025327042 @default.
• W3164716263 creator A5026798359 @default.
• W3164716263 creator A5034763400 @default.
• W3164716263 creator A5036538042 @default.
• W3164716263 creator A5046738565 @default.
• W3164716263 creator A5048216450 @default.
• W3164716263 creator A5063200060 @default.
• W3164716263 creator A5066921477 @default.
• W3164716263 creator A5073501343 @default.
• W3164716263 creator A5074911126 @default.
• W3164716263 creator A5077321144 @default.
• W3164716263 creator A5091874768 @default.
• W3164716263 date "2021-06-01" @default.
• W3164716263 modified "2023-10-15" @default.
• W3164716263 title "Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline" @default.
• W3164716263 cites W1538699145 @default.
• W3164716263 cites W1789208348 @default.
• W3164716263 cites W1964521258 @default.
• W3164716263 cites W1967686468 @default.
• W3164716263 cites W1968096426 @default.
• W3164716263 cites W1972328771 @default.
• W3164716263 cites W1976172820 @default.
• W3164716263 cites W1977041794 @default.
• W3164716263 cites W1978966819 @default.
• W3164716263 cites W1986449058 @default.
• W3164716263 cites W1986947614 @default.
• W3164716263 cites W1987288462 @default.
• W3164716263 cites W1988503785 @default.
• W3164716263 cites W1989470182 @default.
• W3164716263 cites W1995461503 @default.
• W3164716263 cites W2001092660 @default.
• W3164716263 cites W2002120125 @default.
• W3164716263 cites W2003114179 @default.
• W3164716263 cites W2007412122 @default.
• W3164716263 cites W2007524878 @default.
• W3164716263 cites W2009145110 @default.
• W3164716263 cites W2012592483 @default.
• W3164716263 cites W2017344626 @default.
• W3164716263 cites W2017927392 @default.
• W3164716263 cites W2031503463 @default.
• W3164716263 cites W2033527103 @default.
• W3164716263 cites W2040741382 @default.
• W3164716263 cites W2040814774 @default.
• W3164716263 cites W2042567537 @default.
• W3164716263 cites W2048647565 @default.
• W3164716263 cites W2049715299 @default.
• W3164716263 cites W2057388746 @default.
• W3164716263 cites W2060995711 @default.
• W3164716263 cites W2061483147 @default.
• W3164716263 cites W2063401489 @default.
• W3164716263 cites W2066628443 @default.
• W3164716263 cites W2069493394 @default.
• W3164716263 cites W2083680400 @default.
• W3164716263 cites W2084179526 @default.
• W3164716263 cites W2094527573 @default.
• W3164716263 cites W2104447221 @default.
• W3164716263 cites W2108514030 @default.
• W3164716263 cites W2108699935 @default.
• W3164716263 cites W2109883537 @default.
• W3164716263 cites W2111532789 @default.
• W3164716263 cites W2112895275 @default.
• W3164716263 cites W2114614290 @default.
• W3164716263 cites W2114615199 @default.
• W3164716263 cites W2119216632 @default.
• W3164716263 cites W2122487581 @default.
• W3164716263 cites W2140661429 @default.
• W3164716263 cites W2147368252 @default.
• W3164716263 cites W2150824678 @default.
• W3164716263 cites W2154423893 @default.
• W3164716263 cites W2159561976 @default.
• W3164716263 cites W2164782294 @default.
• W3164716263 cites W2165010366 @default.
• W3164716263 cites W2175794335 @default.
• W3164716263 cites W2188066502 @default.
• W3164716263 cites W2219775147 @default.
• W3164716263 cites W2268878707 @default.
• W3164716263 cites W2300039475 @default.
• W3164716263 cites W2307875063 @default.
• W3164716263 cites W2315610784 @default.
• W3164716263 cites W2319710449 @default.
• W3164716263 cites W2335055660 @default.
• W3164716263 cites W2339373103 @default.
• W3164716263 cites W2339767566 @default.
• W3164716263 cites W2339950592 @default.
• W3164716263 cites W2343563077 @default.
• W3164716263 cites W2397074183 @default.
• W3164716263 cites W2441033381 @default.
• W3164716263 cites W2441873555 @default.
• W3164716263 cites W2477913293 @default.

• next